Skip to Content

Pfizer JKI 5 (Xeljanz 5 mg)

Generic Name: tofacitinib

Pill imprint Pfizer JKI 5 has been identified as Xeljanz 5 mg.

Xeljanz is used in the treatment of rheumatoid arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Xeljanz 5 mg Pfizer JKI 5 Front
Xeljanz 5 mg Pfizer JKI 5 Back
Discount Card Promo
Xeljanz
Generic Name:
tofacitinib
Imprint:
Pfizer JKI 5
Strength:
5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Antirheumatics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Pfizer, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide